top of page

Alnylam CEO Yvonne Greenstreet previews 2024

Yvonne Greenstreet talks about how Alnylam has been moving RNAi beyond the liver and previews the year ahead, including HELIOS-B.




תגובות


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page